Therapeutic Group: Others Presentation Finapark TM 50: Each tablet contains Safinamide Mesylate INN equivalent to Safinamide 50 mg. FinaparkTM100: Each tablet contains Safinamide Mesylate INN equivalent to Safinamide 100 mg. Description The precise mechanism by which Safinamide exerts its effect in Parkinson’s disease is unknown. Safinamide inhibits the monoamine oxidase B (MAO-B) activity, by blocking […]
Therapeutic Group: Combined Antihypertensive preparation Presentation Sabitar 50: Each film coated tablet contains Sacubitril Valsartan Sodium Hemipentahydrate INN equivalent to Sacubitril 24 mg and Valsartan 26 mg. Sabitar 100: Each film coated tablet contains Sacubitril Valsartan Sodium Hemipentahydrate INN equivalent to Sacubitril 49 mg and Valsartan 51 mg. Sabitar 200: Each film coated tablet contains […]
Therapeutic Group: Anti Cancer Presentation Rulicent TM 5: Each tablet contains Ruxolitinib Phosphate INN equivalent to Ruxolitinib 5 mg. Rulicent TM 10: Each tablet contains Ruxolitinib Phosphate INN equivalent to Ruxolitinib 10 mg. Description Ruxolitinib is an oral janus kinase (JAK) inhibitor. It contains JAK1 and JAK2 inhibitors which inhibit the signalling of cytokines (small […]
Therapeutic Group: Anti Histamine Presentation Rupex tablet: Each tablet contains Rupatadine Fumarate INN equivalent to Rupatadine 10 mg. Rupex syrup: Each 5 ml syrup contains Rupatadine Fumarate INN equivalent to Rupatadine 5 mg. Description Rupex is a preparation of Rupatadine. Rupatadine is a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. Rupatadine has […]
Therapeutic Group: Anti Bacterial Presentation Pedilid 150: Each film-coated tablet contains Roxithromycin BP 150 mg. Pedilid 300: Each film-coated tablet contains Roxithromycin BP 300 mg. Pedilid powder for suspension: When reconstituted each 5 ml suspension contains Roxithromycin BP 50 mg. Description Roxithromycin, is a macrolide with antibacterial properties similar to erythromycin. It is active against […]
Therapeutic Group: Cardiovascular Presentation Rocovas 5: Each tablet contains Rosuvastatin Calcium INN equivalent to Rosuvastatin 5 mg. Rocovas 10: Each tablet contains Rosuvastatin Calcium INN equivalent to Rosuvastatin 10 mg. Rocovas 20: Each tablet contains Rosuvastatin Calcium INN equivalent to Rosuvastatin 20 mg Description Rosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the […]
Therapeutic Group: Anesthetic / Critical Care Presentation Each vial contains Rocuronium Bromide INN 50 mg injection. Rocuron is supplied in a vial as a clear, aqueous solution for intravenous injection. Description Rocuronium Bromide is a fast onset, intermediate acting non-depolarizing neuromuscular blocking agent, possessing all of the characteristic pharmacological actions of this class of medicines […]
Therapeutic Group: Cardiovascular Presentation Roxarel 10: Each Tablet contains Rivaroxaban INN 10 mg. Roxarel 15: Each Tablet contains Rivaroxaban INN 15 mg. Description Rivaroxaban is a selective inhibitor of clotting factor Xa (FXa). It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban indirectly inhibits […]
Therapeutic Group: Monoclonal Antibody Presentation Relyto 100: Each 10 ml solution for infusion contains Rituximab 100 mg. Relyto 500: Each 50 ml solution for infusion contains Rituximab 500 mg. Description Rituximab is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. […]
Therapeutic Group: Drugs of Nervous System Presentation Frenia 1: Each tablet contains Risperidone BP 1 mg. Frenia 2: Each tablet contains Risperidone BP 2 mg. Frenia 4: Each tablet contains Risperidone BP 4 mg. Frenia Oral Solution: Each 1 ml solution contains Risperidone BP 1 mg. Description Risperidone is a selective monoaminergic antagonist having a […]